{
  "company": {
    "name": "Argonaute RNA",
    "website": "https://argonauterna.com/",
    "record": "https://startuphistory.org/c/argonauterna.com"
  },
  "status": null,
  "history_since": "2018-08-28T06:10:03.000Z",
  "baseline": {
    "snapshot_id": "dfab7ad45df564563e8413d943c3a5c79de13a1bfc746c89b8d1e9b5083065d9",
    "observed_at": "2018-08-28T06:10:03.000Z",
    "headline": "DEVELOPING THERAPIES",
    "description": "Argonaute RNA Limited is developing safe and reliable methods of temporarily silencing target genes in different tissue cells.",
    "evidence": "https://web.archive.org/web/20180828061003/https://argonauterna.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-05T11:25:19.341Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2022-07-02T02:40:12.000Z",
      "variants": [
        {
          "headline": "DEVELOPING THERAPIES",
          "subhead": "Argonaute RNA Limited is developing safe and reliable methods of temporarily silencing target genes in different tissue cells.",
          "observed_at": "2018-08-28T06:10:03.000Z",
          "evidence": "https://web.archive.org/web/20180828061003/https://argonauterna.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "DEVELOPING THERAPIES",
          "subhead": "Argonaute RNA Limited is developing safe and reliable methods of temporarily silencing target genes in different tissue cells.",
          "observed_at": "2021-01-19T16:15:53.000Z",
          "evidence": "https://web.archive.org/web/20210119161553/https://argonauterna.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "DEVELOPING THERAPIES",
          "subhead": "Argonaute RNA Limited is developing safe and reliable methods of temporarily silencing target genes in different tissue cells.",
          "observed_at": "2021-08-04T13:25:02.000Z",
          "evidence": "https://web.archive.org/web/20210804132502/https://argonauterna.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "DEVELOPING THERAPIES",
          "subhead": "Argonaute RNA Limited is developing safe and reliable methods of temporarily silencing target genes in different tissue cells.",
          "observed_at": "2022-07-02T02:40:12.000Z",
          "evidence": "https://web.archive.org/web/20220702024012/https://argonauterna.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "DEVELOPING THERAPIES",
      "subhead": "Argonaute RNA Limited is developing safe and reliable methods of temporarily silencing target genes in different tissue cells.",
      "from": "2018-08-28T06:10:03.000Z",
      "to": "2022-07-02T02:40:12.000Z",
      "captures": 4,
      "evidence": "https://web.archive.org/web/20220702024012/https://argonauterna.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2018-08-28T06:10:03.000Z",
          "to": "2022-07-02T02:40:12.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2025-01-01T13:19:12.000Z",
      "variants": [
        {
          "headline": "BRINGING NOVEL siRNA DRUGS INTO THE CLINIC",
          "subhead": "Argonaute RNA Limited is developing safe and reliable methods of temporarily silencing target genes in different tissue cells.",
          "observed_at": "2023-01-27T02:00:36.000Z",
          "evidence": "https://web.archive.org/web/20230127020036/https://argonauterna.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Bringing novel siRNA drugs into the clinic",
          "subhead": "Developing safe and reliable methods of temporarily silencing target genes in different tissue cells.",
          "observed_at": "2023-12-03T07:30:20.000Z",
          "evidence": "https://web.archive.org/web/20231203073020/https://www.argonauterna.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Bringing novel siRNA drugs into the clinic",
          "subhead": "Developing safe and reliable methods of temporarily silencing target genes in different tissue cells.",
          "observed_at": "2024-03-01T14:17:20.000Z",
          "evidence": "https://web.archive.org/web/20240301141720/https://www.argonauterna.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Bringing novel siRNA drugs into the clinic",
          "subhead": "Developing safe and reliable methods of temporarily silencing target genes in different tissue cells.",
          "observed_at": "2025-01-01T13:19:12.000Z",
          "evidence": "https://web.archive.org/web/20250101131912/https://argonauterna.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Bringing novel siRNA drugs into the clinic",
      "subhead": "Developing safe and reliable methods of temporarily silencing target genes in different tissue cells.",
      "from": "2023-01-27T02:00:36.000Z",
      "to": "2025-01-01T13:19:12.000Z",
      "captures": 4,
      "evidence": "https://web.archive.org/web/20250101131912/https://argonauterna.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2023-01-27T02:00:36.000Z",
          "to": "2025-01-01T13:19:12.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-05T11:25:19.341Z",
      "variants": [
        {
          "headline": "Argonaute Bispecific siRNA",
          "subhead": "Developing safe and reliable methods of temporarily silencing target genes in different tissue cells.",
          "observed_at": "2025-07-18T23:41:12.000Z",
          "evidence": "https://web.archive.org/web/20250718234112/https://argonauterna.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Argonaute Bispecific siRNA",
          "subhead": "Developing safe and reliable methods of temporarily silencing target genes in different tissue cells.",
          "observed_at": "2026-03-12T02:07:45.000Z",
          "evidence": "https://web.archive.org/web/20260312020745/https://argonauterna.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Argonaute Bispecific siRNA",
          "subhead": "Developing safe and reliable methods of temporarily silencing target genes in different tissue cells.",
          "observed_at": "2026-04-21T04:57:08.000Z",
          "evidence": "https://web.archive.org/web/20260421045708/https://argonauterna.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Argonaute Bispecific siRNA",
          "subhead": "Developing safe and reliable methods of temporarily silencing target genes in different tissue cells.",
          "observed_at": "2026-06-14T04:25:04.000Z",
          "evidence": "https://web.archive.org/web/20260614042504/https://argonauterna.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Argonaute Bispecific siRNA",
          "subhead": "Developing safe and reliable methods of temporarily silencing target genes in different tissue cells.",
          "observed_at": "2026-11-05T11:25:19.341Z",
          "evidence": "https://argonauterna.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Argonaute Bispecific siRNA",
      "subhead": "Developing safe and reliable methods of temporarily silencing target genes in different tissue cells.",
      "from": "2025-07-18T23:41:12.000Z",
      "to": "2026-11-05T11:25:19.341Z",
      "captures": 5,
      "evidence": "https://argonauterna.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2025-07-18T23:41:12.000Z",
          "to": "2026-11-05T11:25:19.341Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-b3317648fe8d2a52ff372eaba6021f0e3f7e3efae0e013eb0073e95e3b339a39:a12eb0fd59a91aaae59bf12f0037bd34157160c152a4286b939c98b88a589704:headline:05a27c145bf221be",
      "before_evidence": "https://web.archive.org/web/20220702024012/https://argonauterna.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “DEVELOPING THERAPIES” to “BRINGING NOVEL siRNA DRUGS INTO THE CLINIC”.",
      "between": {
        "from": "2022-07-02T02:40:12.000Z",
        "to": "2023-01-27T02:00:36.000Z"
      },
      "evidence": "https://web.archive.org/web/20230127020036/https://argonauterna.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 2,
      "id": "page-3cde75a553fbcc3556d70c71c480070566bf7d837d05008b8281f386eda8af9d:328ea9b64b5cbcbdd7c076e94b1dee599c9d7add87b29d8ecce204f0e13e1e1c:headline:d4cb6da2bf651d8c",
      "before_evidence": "https://web.archive.org/web/20250101131912/https://argonauterna.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Bringing novel siRNA drugs into the clinic” to “Argonaute Bispecific siRNA”.",
      "between": {
        "from": "2025-01-01T13:19:12.000Z",
        "to": "2025-07-18T23:41:12.000Z"
      },
      "evidence": "https://web.archive.org/web/20250718234112/https://argonauterna.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Argonaute RNA” company record, https://startuphistory.org/c/argonauterna.com"
}